{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,7]],"date-time":"2025-11-07T19:06:50Z","timestamp":1762542410568,"version":"build-2065373602"},"reference-count":21,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"6","funder":[{"DOI":"10.13039\/100008275","name":"University of Florida Health","doi-asserted-by":"crossref","award":["AWD10691"],"award-info":[{"award-number":["AWD10691"]}],"id":[{"id":"10.13039\/100008275","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2025,12]]},"abstract":"<jats:sec>\n                    <jats:title>Background:<\/jats:title>\n                    <jats:p>Data on the effect of extracorporeal membrane oxygenation (ECMO) on cefepime concentration and protein binding are limited. This study aimed to describe the pharmacokinetics of cefepime in patients receiving ECMO, with or without renal replacement therapy.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods:<\/jats:title>\n                    <jats:p>Participants receiving ECMO were prospectively enrolled in the thoracic and lung transplant intensive care unit at the University of Florida Health-Shands Hospital in Gainesville, FL. Serum samples for drug quantification were collected at 1, 2, 4, 6, and 8 hours after the completion of cefepime infusion, pre- and post-ECMO oxygenator. The total and free drug concentrations in the ultrafiltrate were measured using liquid chromatography\u2013tandem mass spectrometry at the University of Florida Infectious Disease Pharmacokinetics Laboratory.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results:<\/jats:title>\n                    <jats:p>Six patients who underwent venovenous ECMO were enrolled in the study. The median [interquartile range (IQR)] age and weight were 56.5 years (48\u201361.8) and 80.6 kg (75.4\u201390.6), respectively, and 67% were female. All patients received 2 g of cefepime infused over 30 minutes, with dosing intervals per renal function. The median (IQR) time between ECMO initiation and pharmacokinetic sampling was 3.5 days (2.5\u201324.7). None of the patients underwent renal replacement therapy during sampling. Minimal differences in cefepime concentrations pre- and postoxygenator were observed (&lt;20% difference for all paired samples; median 3.5%). The median (IQR) protein-binding rates for cefepime both pre- [6.2% (2.6\u201310.8)] and post- [8.7% (2.5\u201313.4)] oxygenator were lower than previously published estimates of 20%.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions:<\/jats:title>\n                    <jats:p>No differences in pre- or post-ECMO oxygenator cefepime concentrations were observed. The median protein-binding values were less than previously published values.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1097\/ftd.0000000000001394","type":"journal-article","created":{"date-parts":[[2025,10,3]],"date-time":"2025-10-03T21:02:55Z","timestamp":1759525375000},"page":"e121-e125","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":0,"title":["Cefepime Pharmacokinetics in Patients Receiving Extracorporeal Membrane Oxygenation"],"prefix":"10.1097","volume":"47","author":[{"given":"Nicole F.","family":"Maranchick","sequence":"first","affiliation":[{"name":"Department of Pharmacotherapy and Translational Research, College of Pharmacy, and Emerging Pathogens Institute, University of Florida, Gainesville, Florida;"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrew","family":"Jaudon","sequence":"additional","affiliation":[{"name":"Department of Respiratory Care, UF Health Shands, Gainesville, Florida;"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Siya","family":"Aparanji","sequence":"additional","affiliation":[{"name":"University of Florida, Gainesville, Florida;"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Emma","family":"Carruthers","sequence":"additional","affiliation":[{"name":"University of Florida, Gainesville, Florida;"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nathalia","family":"Rodriguez","sequence":"additional","affiliation":[{"name":"University of Florida, Gainesville, Florida;"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cristina","family":"Phillips","sequence":"additional","affiliation":[{"name":"Thoracic and Lung Transplant Intensive Care Unit, UF Health Shands, Gainesville, Florida; and"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David","family":"Knott","sequence":"additional","affiliation":[{"name":"Thoracic and Lung Transplant Intensive Care Unit, UF Health Shands, Gainesville, Florida; and"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Abbas","family":"Shahmohammadi","sequence":"additional","affiliation":[{"name":"Lung Transplant and ECMO Program, University of Florida Division of Pulmonary, Critical Care and Sleep Medicine, College of Medicine, Gainesville, Florida."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Charles A.","family":"Peloquin","sequence":"additional","affiliation":[{"name":"Department of Pharmacotherapy and Translational Research, College of Pharmacy, and Emerging Pathogens Institute, University of Florida, Gainesville, Florida;"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mohammad H.","family":"Alshaer","sequence":"additional","affiliation":[{"name":"Department of Pharmacotherapy and Translational Research, College of Pharmacy, and Emerging Pathogens Institute, University of Florida, Gainesville, Florida;"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","published-online":{"date-parts":[[2025,10,3]]},"reference":[{"key":"R2-20251107","doi-asserted-by":"crossref","first-page":"338","DOI":"10.3390\/antibiotics11030338","article-title":"Antibiotics and ECMO in the adult population\u2014persistent challenges and practical guides","volume":"11","author":"Gomez","year":"2022","journal-title":"Antibiotics"},{"key":"R3-20251107","doi-asserted-by":"crossref","first-page":"R194","DOI":"10.1186\/cc11679","article-title":"Sequestration of drugs in the circuit may lead to therapeutic failure during extracorporeal membrane oxygenation","volume":"16","author":"Shekar","year":"2012","journal-title":"Crit Care"},{"key":"R4-20251107","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1164\/rccm.202207-1393OC","article-title":"Antimicrobial exposures in critically ill patients receiving extracorporeal membrane oxygenation","volume":"207","author":"Shekar","year":"2023","journal-title":"Am J Respir Crit Care Med"},{"key":"R5-20251107","first-page":"493","article-title":"Continuous renal replacement therapy during extracorporeal membrane oxygenation: why, when and how?","volume":"24","author":"Ostermann","year":"2018","journal-title":"Curr Opin Crit Care"},{"key":"R6-20251107","doi-asserted-by":"crossref","first-page":"1127","DOI":"10.1007\/s00134-020-06050-1","article-title":"Antimicrobial therapeutic drug monitoring in critically ill adult patients: a position paper","volume":"46","author":"Abdul-Aziz","year":"2020","journal-title":"Intensive Care Med"},{"issue":"suppl 5","key":"R7-20251107","doi-asserted-by":"crossref","first-page":"S629","DOI":"10.21037\/jtd.2017.09.154","article-title":"Optimising drug dosing in patients receiving extracorporeal membrane oxygenation","volume":"10","author":"Cheng","year":"2018","journal-title":"J Thorac Dis"},{"key":"R8-20251107","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1007\/s40262-022-01137-y","article-title":"Clinical pharmacokinetics and pharmacodynamics of cefepime","volume":"61","author":"Pais","year":"2022","journal-title":"Clin Pharmacokinet"},{"key":"R9-20251107","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1128\/AAC.27.2.207","article-title":"Comparison of a new cephalosporin, BMY 28142, with other broad-spectrum beta-lactam antibiotics","volume":"27","author":"Kessler","year":"1985","journal-title":"Antimicrob Agents Chemother"},{"key":"R10-20251107","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1128\/AAC.31.1.55","article-title":"High-pressure liquid chromatographic analysis of BMY-28142 in plasma and urine","volume":"31","author":"Barbhaiya","year":"1987","journal-title":"Antimicrob Agents Chemother"},{"key":"R11-20251107","doi-asserted-by":"crossref","first-page":"e00563-22","DOI":"10.1128\/aac.00563-22","article-title":"Using machine learning to define the impact of beta-lactam early and cumulative target attainment on outcomes in intensive care unit patients with hospital-acquired and ventilator-associated pneumonia","volume":"66","author":"Alshaer","year":"2022","journal-title":"Antimicrob Agents Chemother"},{"key":"R12-20251107","doi-asserted-by":"crossref","first-page":"106727","DOI":"10.1016\/j.ijantimicag.2023.106727","article-title":"Beta-lactam target attainment and associated outcomes in patients with bloodstream infections","volume":"61","author":"Alshaer","year":"2023","journal-title":"Int J Antimicrob Agents"},{"key":"R13-20251107","doi-asserted-by":"crossref","first-page":"1773","DOI":"10.1097\/CCM.0b013e3181eb3ccd","article-title":"Early combination antibiotic therapy yields improved survival compared with monotherapy in septic shock: a propensity-matched analysis","volume":"38","author":"Kumar","year":"2010","journal-title":"Crit Care Med"},{"key":"R14-20251107","doi-asserted-by":"crossref","first-page":"3510","DOI":"10.1128\/AAC.00338-07","article-title":"Predictors of 30-day mortality among patients with Pseudomonas aeruginosa bloodstream infections: impact of delayed appropriate antibiotic selection","volume":"51","author":"Lodise","year":"2007","journal-title":"Antimicrob Agents Chemother"},{"key":"R17-20251107","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1186\/s13054-017-1644-y","article-title":"Medicating patients during extracorporeal membrane oxygenation: the evidence is building","volume":"21","author":"Dzierba","year":"2017","journal-title":"Crit Care"},{"key":"R18-20251107","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1002\/phar.1882","article-title":"Evaluation of altered drug pharmacokinetics in critically ill adults receiving extracorporeal membrane oxygenation","volume":"37","author":"Ha","year":"2017","journal-title":"Pharmacotherapy"},{"key":"R19-20251107","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1051\/ject\/202254212","article-title":"Cefepime extraction by extracorporeal life support circuits","volume":"54","author":"Green","year":"2022","journal-title":"J Extra Corpor Technol"},{"key":"R20-20251107","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1097\/FTD.0000000000000675","article-title":"Meropenem, cefepime, and piperacillin protein binding in patient samples","volume":"42","author":"Al-Shaer","year":"2020","journal-title":"Ther Drug Monit"},{"key":"R22-20251107","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1097\/PCC.0000000000001786","article-title":"A population pharmacokinetic analysis to study the effect of extracorporeal membrane oxygenation on cefepime disposition in children","volume":"20","author":"Zuppa","year":"2019","journal-title":"Pediatr Crit Care Med"},{"key":"R23-20251107","doi-asserted-by":"crossref","first-page":"106466","DOI":"10.1016\/j.ijantimicag.2021.106466","article-title":"Population pharmacokinetics of cefepime in critically ill patients receiving extracorporeal membrane oxygenation (an ASAP ECMO study)","volume":"58","author":"Cheng","year":"2021","journal-title":"Int J Antimicrob Agents"},{"key":"R24-20251107","doi-asserted-by":"crossref","first-page":"1024","DOI":"10.3390\/antibiotics13111024","article-title":"Impact of extracorporeal membrane oxygenation (ECMO) on serum concentrations of cefepime","volume":"13","author":"Destache","year":"2024","journal-title":"Antibiotics"},{"key":"R25-20251107","doi-asserted-by":"crossref","first-page":"102271","DOI":"10.1016\/j.pupt.2023.102271","article-title":"Cefepime pharmacokinetics in adult extracorporeal membrane oxygenation patients","volume":"84","author":"Zheng","year":"2024","journal-title":"Pulm Pharmacol Ther"}],"container-title":["Therapeutic Drug Monitoring"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/FTD.0000000000001394","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,7]],"date-time":"2025-11-07T19:00:31Z","timestamp":1762542031000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/FTD.0000000000001394"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,3]]},"references-count":21,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2025]]}},"URL":"https:\/\/doi.org\/10.1097\/ftd.0000000000001394","relation":{},"ISSN":["0163-4356","1536-3694"],"issn-type":[{"type":"print","value":"0163-4356"},{"type":"electronic","value":"1536-3694"}],"subject":[],"published":{"date-parts":[[2025,10,3]]},"assertion":[{"value":"2025-04-15","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-06-25","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}